Akari Therapeutics (AKTX) Amortization - Intangibles (2015)
Akari Therapeutics recorded quarterly Amortization - Intangibles of $19.3 million in Q3 2015.
Akari Therapeutics' Amortization - Intangibles history runs 1 years deep, the most recent figure standing at $19.3 million for Q3 2015.
- In Q3 2015, Amortization - Intangibles changed N/A year-over-year to $19.3 million; the TTM figure through Dec 2015 stood at $19.3 million (changed N/A YoY), while the FY2015 annual figure was $19.3 million, changed N/A from the prior year.
- Amortization - Intangibles came in at $19.3 million for Q3 2015 at Akari Therapeutics.
- In the past five years, Amortization - Intangibles ranged from a high of $19.3 million in Q3 2015 to a low of $19.3 million in Q3 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 19.28 Mn |